Maintenance endocrine therapy plus bevacizumab for advanced or metastatic breast cancer. Quesada S, Jacot W. Lancet Oncol 2022 Apr 8. pii: S1470-2045(22)00205.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Quesada S, Jacot W. Maintenance endocrine therapy plus bevacizumab for advanced or metastatic breast cancer. Lancet Oncol 2022 Apr 8. pii: S1470-2045(22)00205.
PMID: 35405086